Table 3.
Progestogen | Dose (mg) | Bioavailability (%) | Half-life (h) | Ref. |
---|---|---|---|---|
Progesterone | 100, 200, 300 | <5 | 16.2–18.3 | 16 |
MPA | 10 | >90 | 24 | 17 |
Megestrol acetate | 160 | NA | 22.3 | 18 |
Cyproterone acetate | 2 | NA | 54.0–78.6 | 19 |
Chlormadinone acetate | 2 | ∼100 | 80.1 | 20 |
Medrogestone | 5 | NA | 34.9 | 21 |
Dydrogesterone | 10 | 28 | 14–17 | —a |
Nomegestrol acetate | 2.5 | 60 | 50 | 22 |
Trimegestone | 0.5 | ∼100 | 15 | —a |
Norethindrone | 1 | 64 | 8 | 23 |
Levonorgestrel | 0.15–0.25 | 89/99b | 9.9/13.2b | 24 |
Desogestrel | 0.15 | 62/76b | 11.9/23.8b | 25, 26 |
Gestodene | 0.075 | 87/99b | 12–14 | 27, 28 |
Dienogest | 4 | 96.2 | 10.8/11.6b | 29 |
Drospirenone | 3 | 66 | 31.1–32.5 | 30, 31 |
NA, No data available.
The data were obtained from a package insert.
Multiple bioavailability or half-life values are shown.